Overview

A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adults

Status:
Completed

Trial end date:
2017-06-16

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of multiple-dose administration of probenecid on the pharmacokinetics of JNJ-63549109 and JNJ-64167896 after a single dose of JNJ-64041575 in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

Janssen-Cilag International NV

Treatments:

Probenecid